Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Pharming Technologies B.V.
Sponsor:
Information provided by (Responsible Party):
Pharming Technologies B.V.
ClinicalTrials.gov Identifier:
NCT01359969
First received: May 19, 2011
Last updated: March 12, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)